US EditionPublished • loading... • Updated
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
Summary by Mid Florida Newspapers
3 Articles
3 Articles
Mid Florida NewspapersReposted by 
Weatherford Democrat
Weatherford DemocratIntegrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2025.
Integrated BioPharma (OTCMKTS:INBP) Releases Earnings Results
Integrated BioPharma (OTCMKTS:INBP – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, Zacks reports. Integrated BioPharma had a return on equity of 6.36% and a net margin of 2.37%. Integrated BioPharma Price Performance Shares of OTCMKTS:INBP traded up $0.02 during trading on Tuesday, […]
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
